These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1693001)
1. Interaction of glucagon-like peptide-1 (7-36)amide and cholecystokinin-8 in the endocrine and exocrine rat pancreas. Fehmann HC; Göke B; Weber V; Göke R; Trautmann ME; Richter G; Arnold R Pancreas; 1990 May; 5(3):361-5. PubMed ID: 1693001 [TBL] [Abstract][Full Text] [Related]
2. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas. Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823 [TBL] [Abstract][Full Text] [Related]
3. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas. Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K Metabolism; 1992 Apr; 41(4):359-63. PubMed ID: 1556941 [TBL] [Abstract][Full Text] [Related]
4. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas. Fehmann HC; Göke B; Göke R; Trautmann ME; Arnold R FEBS Lett; 1989 Jul; 252(1-2):109-12. PubMed ID: 2668027 [TBL] [Abstract][Full Text] [Related]
5. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas. Otsuki M; Sakamoto C; Yuu H; Maeda M; Morita S; Ohki A; Kobayashi N; Terashi K; Okano K; Baba S J Clin Invest; 1979 Mar; 63(3):478-84. PubMed ID: 372241 [TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604 [TBL] [Abstract][Full Text] [Related]
7. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas. Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184 [TBL] [Abstract][Full Text] [Related]
8. Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide. Komatsu R; Matsuyama T; Namba M; Watanabe N; Itoh H; Kono N; Tarui S Diabetes; 1989 Jul; 38(7):902-5. PubMed ID: 2661287 [TBL] [Abstract][Full Text] [Related]
9. The effects of two FMRFamide related peptides (A-18-F-amide and F-8-F-amide; 'morphine modulating peptides') on the endocrine and exocrine rat pancreas. Fehmann HC; McGregor G; Weber V; Eissele R; Göke R; Göke B; Arnold R Neuropeptides; 1990 Oct; 17(2):87-92. PubMed ID: 1704109 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro. Guenifi A; Ahrén B; Abdel-Halim SM Pancreas; 2001 Jan; 22(1):58-64. PubMed ID: 11138972 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas. Suzuki S; Kawai K; Ohashi S; Mukai H; Yamashita K Endocrinology; 1989 Dec; 125(6):3109-14. PubMed ID: 2684616 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of pirenzepine on cholecystokinin and secretin stimulation on exocrine and endocrine rat pancreas. Otsuki M; Okabayashi Y; Nakamura T; Fujii M; Oka T; Tani S; Baba S Dig Dis Sci; 1987 Oct; 32(10):1136-44. PubMed ID: 2443324 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases. Kawai K; Suzuki S; Ohashi S; Mukai H; Ohmori H; Murayama Y; Yamashita K Endocrinology; 1989 Apr; 124(4):1768-73. PubMed ID: 2564338 [TBL] [Abstract][Full Text] [Related]
17. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8. Fieseler P; Bridenbaugh S; Nustede R; Martell J; Orskov C; Holst JJ; Nauck MA Am J Physiol; 1995 May; 268(5 Pt 1):E949-55. PubMed ID: 7762650 [TBL] [Abstract][Full Text] [Related]
18. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas. Inoue K; Hisatomi A; Umeda F; Nawata H Horm Metab Res; 1991 Sep; 23(9):407-9. PubMed ID: 1743611 [TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 (7-36 amide): a potent glucagonostatic and insulinotropic hormone. Matsuyama T; Komatsu R; Namba M; Watanabe N; Itoh H; Tarui S Diabetes Res Clin Pract; 1988 Oct; 5(4):281-4. PubMed ID: 3069410 [TBL] [Abstract][Full Text] [Related]
20. Islet amyloid polypeptide (IAPP;amylin) influences the endocrine but not the exocrine rat pancreas. Fehmann HC; Weber V; Göke R; Göke B; Eissele R; Arnold R Biochem Biophys Res Commun; 1990 Mar; 167(3):1102-8. PubMed ID: 1690993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]